The Impact of Medical Services and Medicine Separation Policy on Competitive Pharmaceutical Supply Chain Performance

摘要

This paper takes the performance of pharmaceutical supply chain as the research object, and combines with the medical reform policy to investigates the existing problems of the reform policy. This paper constructs a function model for pharmaceutical companies, hospitals and patients from the perspective of supply chain, and analyzes the decision selection and equilibrium profit of them under different policies. We found that under certain conditions, increasing service prices can increase both patient utility and hospital profit. In the process of medical reform, proper service price can improve the performance of the pharmaceutical supply chain.